March 8, 2021Non-GAAP Reconciliations
2020 Proxy Statement
4Q20 Supplemental Data3Q20 Supplemental Data2Q20 Supplemental Data1Q20 Supplemental Data
2019 Proxy Statement
4Q19 Supplemental Data3Q19 Supplemental Data2Q19 Supplemental Data1Q19 Supplemental Data
2019 Annual Report
2018 Proxy Statement
4Q18 Supplemental Data3Q18 Supplemental Data2Q18 Supplemental Data1Q18 Supplemental Data
2018 Annual Report
2017 Proxy Statement
4Q17 Supplemental Data3Q17 Supplemental Data2Q17 Supplemental Data1Q17 Supplemental Data
2017 Annual Report
2016 Proxy Statement
4Q16 Supplemental Data3Q16 Supplemental Data2Q16 Supplemental Data1Q16 Supplemental Data
2016 Annual Report
2015 Proxy Statement
4Q15 Supplemental Data3Q15 Supplemental Data2Q15 Supplemental Data1Q15 Supplemental Data
2015 Annual Report
2014 Proxy Statement
4Q14 Supplemental Data3Q14 Supplemental Data2Q14 Supplemental Data1Q14 Supplemental Data
2014 Annual Report
2013 Proxy Statement
4Q13 Supplemental Data3Q13 Supplemental Data2Q13 Supplemental Data1Q13 Supplemental Data
2013 Annual Report
4Q12 Supplemental Data3Q12 Supplemental Data2Q12 Supplemental Data1Q12 Supplemental Data
2012 Annual Report
18500 Von Karman Avenue Suite 550 Irvine, CA 92612 888.393.8248
888.393.8248 investorrelations@sabrahealth.com
888.393.8248 assetmanagement@sabrahealth.com
888.393.8248 acquisitions@sabrahealth.com
888.393.8248 humanresources@sabrahealth.com
888.393.8248 mediarelations@sabrahealth.com
Ethics Hotline 888.845.0819
American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn, NY 11219 800.937.5449 amstock.com